Latest from Tuberous Sclerosis Alliance

Sabril Label Expanded for Patients 2 to 10 Years Old

The previously approved therapy is now indicated for treatment in pediatric patients age 2 to 10.

Bcureful and Tuberous Sclerosis Alliance Announce Plans to Combine Efforts

The announcement formally connects Bcureful and the Tuberous Sclerosis Alliance together after working closely together for over the past 8 years.

Important Information About Changes to Access and Availability of Generic Everolimus and Afinitor

The Tuberous Sclerosis Alliance has announced updates to access of everolimus, a drug used to treat several conditions associated with tuberous sclerosis complex.

Tweets by @tsalliance

Tweets by neurology_live

*First Name*Last Name*Email*Verify Email:*Password*Verify Password*Country*State*Sub-specialty*Degree

By registering, you agree to NeurologyLive^®'s Terms and Conditions. Privacy Policy*

Sign Up for Emails to get the Latest Breaking News, Exclusive Event Invites and More*